ESMOGI24
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
ESMOGI24
Jul 1, 2024, 02:54 |
Blog
Erman Akkus: Take home messages from Proffered Papers session at ESMOGI24
Erman Akkus, Medical Oncology Fellow at Ankara University, shared a post on X: “Take home…
Jul 1, 2024, 02:25 |
Blog
Insights from ESMOGI24 by Cathy Eng
ESMO GI 2024 took place from June 26 to 29 in Munich, Germany, featuring both…
Jun 30, 2024, 08:07 |
Societies
9 Posts You Should Not Miss From Day 3 of ESMOGI24!
ESMOGI24 is taking place as an onsite event in Munich, Germany, from 26 to 29 June 2024,…
Jun 30, 2024, 03:43 |
Blog
Pashtoon Kasi: Curative potential of immunotherapy for both MSS and MSI-High tumors
Pashtoon Kasi shared on X: "NEST Trial responses to date. What’s particularly of note is…
Jun 30, 2024, 03:28 |
Blog
Erika Ruiz-Garcia: GI oncology team from National Institute of Cancerology will present 6 posters at ESMOGI24
Erika Ruiz-Garcia, Chief of the Translational Medicine Laboratory at the National Institute of Cancerology in Mexico…
Jun 29, 2024, 14:24 |
Societies
KRAS - the most commonly mutated oncogene in cancer
Amol Akhade shared on X: "KRAS - the most commonly mutated oncogene in cancer. Nice…
Jun 29, 2024, 13:41 |
Societies
ESMOGI24 Key Insights Shared By Megan Barnet
ESMOGI24 is taking place as an onsite event in Munich, Germany, from 26 to 29…
Jun 29, 2024, 13:12 |
Societies
Poster on early-onset CCA won Best Poster at ESMOGI24
Natalia Tissera, PhD Student at Vall d'Hebron Institute of Oncology (VHIO), shared on X: "Thrilled…
Jun 29, 2024, 12:39 |
Societies
Rachel Riechelmann: Excellent discussion of neoadjuvant IO in colorectal cancer
Rachel Riechelmann shared on X: "Excellent discussion of neoadjuvant IO in colorectal cancer by Juan O'Connor…
Jun 29, 2024, 11:21 |
Societies
Highlights from ESMOGI24 by Angela Lamarca
ESMO GI 2024 is taking place as an onsite event in Munich, Germany, from 26 to 29…
1
2
3
4
5
6
All:
54
Posts:
1 - 10
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube